High Survivin Expression in Ductal Carcinoma In Situ (DCIS): A Potential Therapeutic Target

E-ISSN： 1875-6301|8|3|189-196

ISSN： 1573-3947

Source： Current Cancer Therapy Reviews, Vol.8, Iss.3, 2012-08, pp. : 189-196

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

p53 protein expression in ductal carcinoma in situ (DCIS) of the breast

By Rajan P.B.

Breast Cancer Research and Treatment, Vol. 42, Iss. 3, 1997-02 ,pp. : 283-290

Springer Publishing Company

Access to resources Recommend Favorite

Histopathology of Ductal Carcinoma in Situ (DCIS) of the Breast

Current Cancer Therapy Reviews, Vol. 8, Iss. 3, 2012-08 ,pp. : 162-171

Bentham Science Publishers

Access to resources Recommend Favorite

Increased SIAH expression predicts ductal carcinoma in situ (DCIS) progression to invasive carcinoma

By Behling Kathryn

Breast Cancer Research and Treatment, Vol. 129, Iss. 3, 2011-10 ,pp. : 717-724

Springer Publishing Company

Access to resources Recommend Favorite

Upregulation of focal adhesion kinase (FAK) expression in ductal carcinoma in situ (DCIS) is an early event in breast tumorigenesis

By Lightfoot Harry M.

Breast Cancer Research and Treatment, Vol. 88, Iss. 2, 2004-11 ,pp. : 109-116

Springer Publishing Company

Access to resources Recommend Favorite

Cosmesis Outcomes for Sector Resection for Ductal Carcinoma In Situ (DCIS)

By Fosh Beverley Hainsworth Alison Beumer Jesse Howes Benjamin McLeay William Eaton Michael

Annals of Surgical Oncology, Vol. 21, Iss. 4, 2014-04 ,pp. : 1271-1275

Springer Publishing Company

Access to resources Recommend Favorite